The in-between: Thinking togetherness without the common (Agamben, Levinas, Buber)
Is this your thesis?
This record came from a bulk archive import. If it’s yours, link it to your profile.
Abstract (EN)
From ancient times to contemporary discussions, the concept of 'togetherness' is discussed within the frame of 'being together', 'being-with-other/s', on account of the 'community' that centered around subject of the 'I'. This thesis argues that thinking togetherness without the common that is the in-between, rather than 'being together'. Additionally, in this thesis it is claimed that thinking togetherness without the common as the in-between, is only constituted through Lyotard's concept of 'phrase' which gives us the ground of the possibility of a community without something common. Agamben's concept of 'whatever singularity', Buber's primary word 'I-Thou', and Levinas's concept of 'other' are discussed in terms of thinking togetherness without the common that is the in-between. This thesis aims to emphasize that there is an alternative way of understanding the question 'How do we live together?' in terms of togetherness without the common.
Author
Fikriye Gözde Mocan
How to Cite
Fikriye Gözde Mocan (Doctorate thesis). The in-between: Thinking togetherness without the common (Agamben, Levinas, Buber), 2019, Yeditepe University.
License
Tüm Hakları Saklıdır
This work is shared under the specified license terms.
More theses from Yeditepe University
- Studies on cyclodextrin complexation of a poorly water soluble anti-hyperlipidemic drug, tablet formulation and characterization(2021)
- Washington ambassadors in Turkish-US relations (1927-1960)(2023)
- Metamorphosis of female voices: A study of the violation of women in Greek and Roman mythology and feminist rewritings reclaiming the narrative(2022)
- Knowledge distillation with foundation models for image segmentation(2023)
- The relationship between machiavelism, grandiose and vulnerable narcissism, and loneliness among white collar workers(2023)
- Evaluation of drug-drug interaction checkers along clinically relevant adverse drug events in oncology and hematology pediatric patients(2023)